ERBB2 and hepatocellular carcinoma: In summary, our results discover the lncRNA MYLK-AS1 activating EGFR/HER2-ERK signaling pathway and disclose the pivotal role of MYLK-AS1 in promoting HCC cell proliferation, migration and invasion.